123 related articles for article (PubMed ID: 15015639)
1. Immunohistochemical studies of the expression of matrix metalloproteinase-2 and metalloproteinase-9 in human prostate cancer.
Zeng H; Xiao Y; Lu G; Chen Y
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):373-4, 379. PubMed ID: 15015639
[TBL] [Abstract][Full Text] [Related]
2. [Significance of MMP2 and MMP9 expression in prostate cancer].
Zhang XY; Hong BF; Chen GF; Lu YL; Zhong M
Zhonghua Nan Ke Xue; 2005 May; 11(5):359-61, 364. PubMed ID: 15934460
[TBL] [Abstract][Full Text] [Related]
3. [Significance of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase and protein Ki-67 in prostate tumors].
Babichenko II; Pul'bere SA; Motin PI; Loktev AV; Abud M
Urologiia; 2014; (5):82-6. PubMed ID: 25807766
[TBL] [Abstract][Full Text] [Related]
4. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.
Mehta PB; Jenkins BL; McCarthy L; Thilak L; Robson CN; Neal DE; Leung HY
Oncogene; 2003 Mar; 22(9):1381-9. PubMed ID: 12618764
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Gilardoni MB; Remedi MM; Oviedo M; Dellavedova T; Sarría JP; Racca L; Dominguez M; Pellizas CG; Donadio AC
Pathol Res Pract; 2017 Jan; 213(1):66-71. PubMed ID: 27931798
[TBL] [Abstract][Full Text] [Related]
6. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
[TBL] [Abstract][Full Text] [Related]
7. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
9. [Localization and expression of matrix metalloproteinase-7 in human prostate].
Hashimoto K; Yano A; Tanabe T; Usui T; Kihira Y; Matsuo Y
Nihon Hinyokika Gakkai Zasshi; 1997 Oct; 88(10):852-7. PubMed ID: 9388364
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic transformation of human benign prostate hyperplasia with chronic cadmium exposure.
Prajapati A; Chauhan G; Shah H; Gupta S
J Trace Elem Med Biol; 2020 Dec; 62():126633. PubMed ID: 32818862
[TBL] [Abstract][Full Text] [Related]
11. [Expression of cyclooxygenase-2 and vascular endothelial growth factor in human prostate cancer and its significance].
Jin TX; Li XG; Wu WY; Piao DM; Feng JY; Sang J
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):207-10. PubMed ID: 16597032
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate.
Hashimoto K; Kihira Y; Matuo Y; Usui T
J Urol; 1998 Nov; 160(5):1872-6. PubMed ID: 9783977
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
14. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
[TBL] [Abstract][Full Text] [Related]
15. PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion.
Brown-Clay JD; Shenoy DN; Timofeeva O; Kallakury BV; Nandi AK; Banerjee PP
Oncotarget; 2015 Jun; 6(17):15594-609. PubMed ID: 25909225
[TBL] [Abstract][Full Text] [Related]
16. Finasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulation.
Moroz A; Delella FK; Almeida R; Lacorte LM; Fávaro WJ; Deffune E; Felisbino SL
PLoS One; 2013; 8(12):e84757. PubMed ID: 24386413
[TBL] [Abstract][Full Text] [Related]
17. Dickkopf-3 regulates prostate epithelial cell acinar morphogenesis and prostate cancer cell invasion by limiting TGF-β-dependent activation of matrix metalloproteases.
Romero D; Al-Shareef Z; Gorroño-Etxebarria I; Atkins S; Turrell F; Chhetri J; Bengoa-Vergniory N; Zenzmaier C; Berger P; Waxman J; Kypta R
Carcinogenesis; 2016 Jan; 37(1):18-29. PubMed ID: 26503968
[TBL] [Abstract][Full Text] [Related]
18. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA
Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574
[TBL] [Abstract][Full Text] [Related]
19. Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.
Reis ST; Antunes AA; Pontes-Junior J; Sousa-Canavez JM; Dall'Oglio MF; Piantino CB; Cruz JA; Morais DR; Srougi M; Leite KR
Int Braz J Urol; 2012; 38(2):167-74. PubMed ID: 22555040
[TBL] [Abstract][Full Text] [Related]
20. [The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].
Ouyang YW; Peng ZL; Yao XY; Liu SL; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):330-3. PubMed ID: 15181827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
